Modulation of TonEBP activity by SUMO modification in response to hypertonicity.

Citation data:

Frontiers in physiology, ISSN: 1664-042X, Vol: 5, Page: 200

Publication Year:
2014
Usage 6
Abstract Views 5
Link-outs 1
Captures 7
Readers 7
Social Media 1
Tweets 1
Citations 5
Citation Indexes 5
Repository URL:
http://scholarworks.unist.ac.kr/handle/201301/5421
PMID:
24994984
DOI:
10.3389/fphys.2014.00200
PMCID:
PMC4063170
Author(s):
Kim, Jeong-Ah; Kwon, Mi Jin; Lee-Kwon, Whaseon; Choi, Soo Youn; Sanada, Satoru; Kwon, Hyug Moo
Publisher(s):
Frontiers Media SA; Frontiers Research Foundation
Tags:
Biochemistry, Genetics and Molecular Biology; Medicine; Renal medulla; TonEBP; Transactivation
Most Recent Tweet View All Tweets
article description
TonEBP is a DNA binding transcriptional enhancer that enables cellular adaptation to hypertonic stress by promoting expression of specific genes. TonEBP expression is very high in the renal medulla because local hypertonicity stimulates its expression. Given the high level of expression, it is not well understood how TonEBP activity is modulated. Here we report that TonEBP is post-translationally modified by SUMO, i.e., sumoylated, in the renal medulla but not in other isotonic organs. The sumoylation is reproduced in cultured cells when switched to hypertonicity. Analyses of site-directed TonEBP mutants reveal that K556 and K603 are independently sumoylated in response to hypertonicity. DNA binding is required for the sumoylation. Functional analyses of non-sumoylated mutants and SUMO-conjugated constructs show that sumoylation inhibits TonEBP in a dose-dependent manner but independent of the site of SUMO conjugation. Sumoylation inhibits transactivation without affecting nuclear translocation or DNA binding. These data suggest that sumoylation modulates the activity of TonEBP in the hypertonic renal medulla to prevent excessive action of TonEBP.